Lung Deposition of BDP/Formoterol HFA pMDI in Healthy Volunteers, Asthmatic, and COPD Patients

BACKGROUND: When inhaling medication, it is essential that drug particles are delivered to all sites of lung inflammation, including the peripheral airways. The aim of this study was to assess the lung deposition and lung distribution of beclomethasone dipropionate (BDP)/formoterol (100/6 μg), both...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: De Backer, Wilfried, Devolder, Annick, Poli, Gianluigi, Acerbi, Daniela, Monno, Raffaella, Herpich, Christiane, Sommerer, Knut, Meyer, Thomas, Mariotti, Fabrizia
Format: Artigo
Langue:Inglês
Publié: Mary Ann Liebert, Inc. 2010
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3123836/
https://ncbi.nlm.nih.gov/pubmed/20109122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jamp.2009.0772
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires